- Exchange: New York
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Medical Products
Snapshot for Covidien PLC (COV)
| Open: | 65.6700 | Day's Range: | 65.4850 - 66.0500 | Volume: | 2,652,403 |
|---|---|---|---|---|---|
| Previous Close: | 65.7700 | 52wk Range: | 50.2500 - 68.8300 | 1-Yr Rtn: | +26.43% |
Key Statistics for COV
| Current P/E Ratio (ttm) | 15.0923 |
|---|---|
| Estimated P/E(09/2013) | 15.6335 |
| Relative P/E vs. SPX | 0.9250 |
| Earnings Per Share (USD) (ttm) | 4.3578 |
| Est. EPS (USD) (09/2013) | 4.2070 |
| Est. PEG Ratio | 1.7221 |
| Market Cap (M USD) | 30,943.12 |
| Shares Outstanding (M) | 470.47 |
| 30 Day Average Volume | 3,178,272 |
| Price/Book (mrq) | 2.8178 |
| Price/Sale (ttm) | 2.5686 |
| Dividend Indicated Gross Yield | 1.58% |
| Cash Dividend (USD) | 0.2600 |
| Last Dividend | 04/02/2013 |
| 5 Year Dividend Growth | 15.93% |
| Next Earnings Announcement | 07/26/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for COV
Company Profile & Key Executives for COV
Covidien PLC is a global healthcare products company. The Company develops, manufactures and distributes a diverse range of medical devices and supplies, diagnostics imaging agents, pharmaceuticals and other healthcare products for use in clinical and home settings.
| Jose E Almeida "Joe"Chairman/President/CEO | Peter L WehrlyGroup Pres:Vascular Therepies |
| Charles J Dockendorff "Chuck"Exec VP/CFO | Mark C TrudeauSenior VP/Pres:Pharmaceuticals |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
COV News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page